Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.06
-0.11
(-5.07%)
USD |
NASDAQ |
Nov 06, 15:22
Bridgebio Oncology Therapeutics Net Income (TTM) : -182.11M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -182.11M |
| March 31, 2026 | -154.10M |
| December 31, 2025 | -134.04M |
| September 30, 2025 | -114.93M |
| June 30, 2025 | -87.50M |
| Date | Value |
|---|---|
| March 31, 2025 | -56.85M |
| December 31, 2024 | -33.70M |
| September 30, 2024 | -14.05M |
| June 30, 2024 | 3.268M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Korsana Biosciences, Inc. | -6.707M |
| IRulya Therapeutics, Inc. | -92.48M |
| PepGen Inc. | -71.94M |
| Q32 Bio, Inc. | 32.25M |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |